185 related articles for article (PubMed ID: 26962283)
1. Percutaneous Image-guided Radiofrequency Ablation of Tumors in Inoperable Patients - Immediate Complications and Overall Safety.
Sahay A; Sahay N; Kapoor A; Kapoor J; Chatterjee A
Indian J Palliat Care; 2016; 22(1):67-73. PubMed ID: 26962283
[TBL] [Abstract][Full Text] [Related]
2. Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2011; 11(1):1-93. PubMed ID: 23074413
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. CT-guided percutaneous minimally invasive radiofrequency ablation for the relief of cancer related pain from metastatic non-small cell lung cancer patients: a retrospective study.
Zhou X; Li H; Qiao Q; Pan H; Fang Y
Ann Palliat Med; 2021 Feb; 10(2):1494-1502. PubMed ID: 33302633
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches.
Machi J; Uchida S; Sumida K; Limm WM; Hundahl SA; Oishi AJ; Furumoto NL; Oishi RH
J Gastrointest Surg; 2001; 5(5):477-89. PubMed ID: 11985998
[TBL] [Abstract][Full Text] [Related]
6. Computed tomographic-guided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location: Evaluation of safety and technical efficacy.
Liu CH; Yu CY; Chang WC; Dai MS; Hsiao CW; Chou YC; Huang GS
J Chin Med Assoc; 2016 Feb; 79(2):93-100. PubMed ID: 26507775
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
8. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
9. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL
Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741
[TBL] [Abstract][Full Text] [Related]
10. [Ultrasound-guided assistant infusion technique for percutaneous radiofrequency ablation of liver cancer].
Han Y; Hao YZ; Cai JQ; Yang M; Liu S; He LF; Yu L; Chen MH
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):266-9. PubMed ID: 22964146
[TBL] [Abstract][Full Text] [Related]
11. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.
del Cura JL; Zabala R; Iriarte JI; Unda M
Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208
[TBL] [Abstract][Full Text] [Related]
12. Treatment Failure After Image-Guided Percutaneous Radiofrequency Ablation (RFA) of Renal Tumors - A Systematic Review with Description of Type, Frequency, Risk Factors and Management.
Vollherbst D; Bertheau R; Kauczor HU; Radeleff BA; Pereira PL; Sommer CM
Rofo; 2017 Mar; 189(3):219-227. PubMed ID: 27627446
[No Abstract] [Full Text] [Related]
13. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.
Wood TF; Rose DM; Chung M; Allegra DP; Foshag LJ; Bilchik AJ
Ann Surg Oncol; 2000 Sep; 7(8):593-600. PubMed ID: 11005558
[TBL] [Abstract][Full Text] [Related]
15. Endobronchial ultrasound-guided bipolar radiofrequency ablation for lung cancer: A first-in-human clinical trial.
Ishiwata T; Motooka Y; Ujiie H; Inage T; Gregor A; Aragaki M; Chen Z; Kinoshita T; Donahoe L; Yeung J; Cypel M; de Perrot M; Pierre A; Darling G; Waddell T; Keshavjee S; Pal P; Yasufuku K
J Thorac Cardiovasc Surg; 2022 Oct; 164(4):1188-1197.e2. PubMed ID: 35459539
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided radiofrequency ablation (RFA) for inoperable gastrointestinal liver metastases.
Hofer S; Oberholzer C; Beck S; Looser C; Ludwig C
Ultraschall Med; 2008 Aug; 29(4):388-92. PubMed ID: 18785319
[TBL] [Abstract][Full Text] [Related]
17. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
[TBL] [Abstract][Full Text] [Related]
19. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
Chen MH; Yan K; Yang W; Gao W; Dai Y; Huo L; Zhang H; Huang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):671-2. PubMed ID: 16378128
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
